1Chang WL, Yang YH, Lin YT, et al.Gastro intestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients. Acta Pediatr,2004,93:1427-1431.
2Evans-Jones LG, Clough JV.Thrombocytosis in Henoch-Schonlein syndrome. Clin Lab Haematol,1990,12:137-139.
3Eldor A, Avitzour M, Or R, et al. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J, 1982,285:397-400.
4Bitton A, Peppercorn MA. Emergencies in inflammatory bowel disease. Crit Care Clin,1995,11:513-529.
5Reddy SB, Jeejeebhoy KN.Acute complications of Crohn's disease. Crit Care Med,1988,16:557-561.
6Lin CY, Yang YH, Lee CC,et al. Thrombopoietin and interleukin- 6 levels in Henoch-Schnlein purpura. J Microbiol Immunol Infect,2006,39:476-482.
5de Almeida JL,Campos LM,Paim LB,et al.Renal involvement in Henoch-Schonlein purpura;a multivariate analysis of initial prognostic factors[].The Journal of Pediatrics.2007
6Pohl M. Henoch-Sch鰊lein purpura nephritis [J]. PediatrNephrol, 2015, 30(2): 245-252.
7Iwaki T, Urano T, Umemura K. PAI-1, progress inunderstanding the clinical problem and its aetiology [J]. BrJ Haematol, 2012, 157(3): 291-298.
8Eriksson P, Kallin B, van抰 Hooft FM, et al. Allele-specificincrease in basal transcription of the plasminogen-activatorinhibitor 1 gene is associated with myocardial infarction [J].Proc Natl Acad Sci USA, 1995, 92(6): 1851-1855.
9Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PreS endorsedconsensus criteria for the classification of childhoodvasculitides [J]. Ann Rheum Dis, 2006, 65(7): 936-941.
10Besbas N, Erbay A, Saat U, et al. Thrombomodulin, tissueplasminogen activator and plasminogen activator inhibitor-1in Henoch-Schlein purpura [J]. Clin Exp Rheumatol,1998, 16(1): 95-98.
